Adenocarcinoma, the most common subtype, is often peripheral, commonly found in non-smokers, and expresses markers like TTF-1, Napsin A, and CK7, with potential mutations in EGFR and ALK that can be targeted with specific therapies [15]. Here, ALK is linked to adenocarcinoma.